SCHEMBL4763506

SCHEMBL4763506

CCn1c(=O)c([N+](=O)[O-])c(C)n(CCCOC)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 12/20 0.40
ADORA2A P29274 8/20 0.40
PARG Q86W56 1/20 0.39
ALDH1A1 P00352 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
AGTR1 P30556 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TLR9 Q9NR96 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772714 0.85 ADORA2B (0.39) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4771669 0.84 ALDH1A1 (0.41) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4057548 0.82 ALDH1A1 (0.44) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4763504 0.82 ADORA2B (0.46) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4769165 0.80 PDE4A (0.39) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4763151 0.77 ALDH1A1 (0.40) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4229116 0.76 ADORA2A (0.40) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4767319 0.76 ALDH1A1 (0.42) ADORA2BADORA2AALDH1A1PDE4APDE4B
SCHEMBL4865970 0.76 ADORA2B (0.40) ADORA2BADORA2APARGALDH1A1PDE4A
SCHEMBL4763645 0.74 SIRT1 (0.40) ADORA2BADORA2APARGALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed